67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE — Jordi Bruix (2009) | RDL Network
67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE
Peter R. Galle, Jean–Frédéric Blanc, Jean‐Luc Van Laethem, J. Marrero, Michel Beaugrand, M. Moscovici, Ming Shan, Andrea Nadel, D. Voliotis, Jordi Bruix, Josep M. Llovet
Francesco Vitiello, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Mario Scartozzi, Emiliano Tamburini, Francesco Giuseppe Foschi, Mara Persano, Federico Rossari, Silvia Foti, Silvia Camera, ,
Jean‐Luc Raoul, Armando Santoro, Michel Beaugrand, Jorge A. Marrero, M. Moscovici, Minghua Shan, Andrea Nadel, D. Voliotis, Jordi Bruix, Josep M. Llovet
Discussion(0)
No comments yet. Be the first to comment.